artemether has been researched along with Malaria in 243 studies
*Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (9.05) | 18.7374 |
| 1990's | 12 (4.94) | 18.2507 |
| 2000's | 61 (25.10) | 29.6817 |
| 2010's | 62 (25.51) | 24.3611 |
| 2020's | 86 (35.39) | 2.80 |
| Authors | Studies |
|---|---|
| Brossi, A; Buchs, P; Dominguez Gerpe, L; Flippen-Anderson, JL; Luo, XD; Milhous, W; Peters, W; Venugopalan, B; Yeh, HJ | 1 |
| Bégué, JP; Bonnet-Delpon, D; Doury, JC; Gantier, JC; Ménage, C; Pradines, B; Thac, TD; Thanh Nga, TT | 1 |
| Ager, AL; Andersen, SL; Dong, Y; Edwards, G; Fu, H; Gerena, L; Holme, AD; Kyle, DE; McLean, WG; Milhous, WK; Miller, RE; Vennerstrom, JL; Walters, SM; Wesche, DL; Wood, JK | 1 |
| Bishop, LP; Hindley, S; Maggs, JL; Miller, A; O'Neill, PM; Park, BK; Posner, GH; Roberts, SM; Scheinmann, F; Stachulski, AV; Ward, SA | 1 |
| Bray, PG; Davies, J; Hindley, S; O'Neill, PM; Park, BK; Searle, NL; Storr, RC; Ward, SA | 1 |
| Bachi, MD; Hoos, R; Korshin, EE; Ploypradith, P; Posner, GH; Shapiro, TA; Szpilman, AM; Xie, S | 1 |
| Bégué, JP; Bonnet-Delpon, D; Charman, WN; Charneau, S; Chorki, F; Crousse, B; Grellepois, F; Grellier, P; McIntosh, KA; Ourévitch, M; Pradines, B | 1 |
| Brun, R; Charman, SA; Charman, WN; Chiu, FC; Chollet, J; Dong, Y; Dorn, A; Karle, JM; Matile, H; Santo Tomas, J; Scheurer, C; Scorneaux, B; Snyder, C; Tang, Y; Urwyler, H; Vennerstrom, JL; Wang, X; Wittlin, S | 1 |
| Brun, R; Charman, SA; Charman, WN; Chollet, J; Creek, DJ; Dong, Y; Matile, H; Padmanilayam, M; Scheurer, C; Scorneaux, B; Tomas, JS; Vennerstrom, JL; Wittlin, S | 1 |
| Becker, K; Davioud-Charvet, E; Friebolin, W; Furrer, J; Jannack, B; Lanzer, M; Oeser, T; Sanchez, CP; Wenzel, N; Yardley, V | 1 |
| Chen, X; Hergenrother, PJ; Liu, JO; Posner, GH; Rosenthal, AS; Shapiro, TA; West, DC | 1 |
| Beck, HP; Brun, R; Cohen, SB; Dartois, V; Dharia, NV; Diagana, TT; Fidock, DA; Goh, A; González-Páez, GE; Jegla, T; Keller, TH; Lakshminarayana, SB; Lee, MC; McNamara, C; Nosten, F; Plouffe, DM; Renia, L; Rottmann, M; Russell, B; Schmitt, EK; Seitz, P; Spencer, KR; Suwanarusk, R; Tan, J; Winzeler, EA; Yeung, BK; Zou, B | 1 |
| Amewu, R; Berger, O; Berry, NG; Biagini, GA; Charoensutthivarakul, S; Fisher, NE; Gibbons, P; Hill, A; Hong, WD; Leung, SC; Mbekeani, A; Nixon, GL; O'Neill, PM; Pacorel, B; Pidathala, C; Sharma, R; Shone, AE; Srivastava, A; Stocks, PA; Taylor, L; Ward, SA; Warman, AJ | 1 |
| Biamonte, MA; Le Roch, KG; Wanner, J | 1 |
| Conyers, RC; Mazzone, JR; Posner, GH; Sullivan, DJ; Tripathi, AK | 1 |
| Abuaku, B; Afriyie, PO; Bart-Plange, C; Duah-Quashie, NO; Ghansah, A; Gyasi, A; Koram, KA; Malm, KL; Owusu-Antwi, F; Quashie, N | 1 |
| Apat, D; Carter, J; Igunza, P; Kimori, J; Kinyari, T; Kiplimo, R; Langat, B; Marita, E; Muhula, S | 1 |
| Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G | 1 |
| Amaratunga, C; Callery, JJ; Chau, NH; Chotivanich, K; Chotsiri, P; Day, NPJ; Dhorda, M; Dondorp, AM; Duanguppama, J; Dung, NTP; Hien, TT; Hoglund, RM; Imwong, M; Lek, D; Long, LT; Maude, RJ; Miotto, O; Mukaka, M; Nghia, HDT; Nguon, C; Peto, TJ; Rekol, H; Ruecker, A; Sokha, M; Sovann, Y; Tarning, J; Thuong, NTH; Tripura, R; van der Pluijm, RW; Van Luong, V; von Seidlein, L; Waithira, N; White, NJ | 1 |
| Bauleni, A; Buchwald, AG; Chilombe, M; Coalson, JE; Cohee, LM; Laufer, MK; Mathanga, DP; Ngwira, A; Peterson, I; Schaffer-DeRoo, S; Seydel, KB; Taylor, TE; Valim, C; Wilson, ML | 1 |
| Bottieau, E; Huits, R; Rosanas-Urgell, A; Tournoy, TK; Van Esbroeck, M | 1 |
| Atieli, H; Debrah, I; Githeko, AK; Githure, J; Kazura, J; Lee, MC; Magomere, EO; Mukabana, WR; Ochwedo, KO; Olumeh, JO; Onyango, P; Otambo, WO; Ouma, C; Wang, C; Yan, G; Zhou, G | 1 |
| Asinya, M; Jeuronlon, MK; Kamara, P; Koko, VS; Kollie, A; Ma, L; Menard, D; Nyansaiye, P; Parwon, S; Pratt, OJ; Ringwald, P; Taweh, F; Tehmeh, L; Vonhm, B; Warsame, M | 1 |
| Basco, LK; Briolant, S; Casimiro, PN; Kobawila, SC; Matondo Diassivi, B; Ndounga, M; Pembet Singana, B; Ringwald, P; Youndouka, JM | 1 |
| Ashaba, FK; Edgar, K; Kamya, MR; Mwesigwa, S; Nsobya, SL; Ocan, M | 1 |
| Grundmann, O; Hernandez Maldonado, J | 1 |
| Balizou, O; Biago, U; Gody, JC; Moyen, M; Nambei, WS; Ndoua, C; Pounguinza, S | 1 |
| Batty, KT; Bwire, GM; Davis, TME; Makani, J; Manning, L; Minzi, OMS; Moore, BR; Ngasala, B; Page-Sharp, M; Salman, S; Sugiarto, SR | 1 |
| Baguiya, A; Barry, N; Burri, C; Dianda, F; Hien, D; Kaboré, JMT; Nombré, Y; Siribié, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB | 1 |
| Hezagira, N; Riewpaiboon, A; Youngkong, S | 1 |
| Esfahani, G; Häusler, O; Mäder, K | 1 |
| Adeniji, OE; Amambua-Ngwa, A; Amawu, AU; Correa, S; Faal, F; Heinz, E; Hughes, G; Meremikwu, MM; Oboh, MA; Ogban, E | 1 |
| Amante, FH; Barber, BE; Birrell, GW; Edstein, MD; Gower, J; Heunis, J; Jennings, H; Llewellyn, S; Lynch, S; Marquart, L; McCarthy, JS; Mitchell, H; O'Neill, B; Peters, JM; Potter, AJ; Shanks, GD; Webster, R | 1 |
| Baguiya, A; Barry, N; Hien, D; Kaboré, JMT; Siribié, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB | 1 |
| Abuom, D; Akala, HM; Andagalu, B; Chemwor, G; Cheruiyot, A; Cowden, J; Juma, D; Kamau, E; Ogutu, B; Okoth, R; Okudo, C; Onyango, I; Opot, B; Sifuna, P; Wafubwa, J; Watson, OJ; Yalwala, S; Yeda, R | 1 |
| Amambua-Ngwa, A; Bojang, F; D'Alessandro, U; Demba, MA; Diop, MF; Jeffries, D; Mane, K; Mbye, H; Mohammed, NI; Quashie, NB | 1 |
| Abdallah, KS; Bacar, A; Deng, C; Li, G; Li, M; Liu, R; Lu, C; Silai, R; Song, J; Tan, R; Wu, W; Xu, Q; Yuan, Y; Zhang, H; Zheng, S | 1 |
| Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jaiteh, FK; Oboh, M; Oriero, E; Tadele, G | 1 |
| Buff, AM; Chebore, W; Desai, M; Kariuki, S; Otieno, K; Owidhi, M; Samuels, AM; Westercamp, N | 1 |
| Barnes, KI; Berghmans, PJ; Chalon, S; Chughlay, MF; El Gaaloul, M; Escoffier, E; Flynn, J; Gobeau, N; Izquierdo-Juncàs, D; Jansen, B; Kümmel, A; Marx, MW; Mitov, V; Möhrle, JJ; Rosanas-Urgell, A; Van Geertruyden, JP; Van Leuven, K | 1 |
| Kamugisha, E; Konje, ET; Liwa, AC; Marwa, KJ; Mwita, S; Swedberg, G | 1 |
| Aweeka, FT; Colt, M; Goodwin, J; Huang, L; Kajubi, R; Li, F; Mwebaza, N; Orukan, F; Parikh, S; Richards, K; Wang, K; Whalen, ME | 1 |
| Callery, JJ; Chotthanawathit, P; Conradis-Jansen, F; Dondorp, AM; Duanguppama, J; Ean, M; Heng, C; Imwong, M; Jongdeepaisal, M; Khonputsa, P; Madmanee, W; Maude, RJ; Mukaka, M; Peerawaranun, P; Pell, C; Peto, TJ; Pongsoipetch, K; Rekol, H; Sokha, M; Sovannaroth, S; Soviet, U; Tarning, J; Tripura, R; von Seidlein, L; Waithira, N; White, NJ | 1 |
| Dondorp, AM; Maude, RJ; Tarning, J; von Seidlein, L; White, NJ | 1 |
| Alemayehu, GS; Dinka, H; Golassa, L; Hassen, J | 1 |
| Aweeka, F; Ehrlich, H; Freeman, T; French, J; Goodwin, J; Huang, L; Kajubi, R; Kay, K; Li, F; Mwebaza, N; Ou, J; Parikh, S; Riggs, M; Ruiz-Garcia, A; Wade, M; Wang, K | 1 |
| Bibe, AF; Earland, DE; Ferrão, J; Novela, A; Searle, KM | 1 |
| Adegnika, AA; Akinosho, MA; Davi, SD; Dimessa-Mbadinga, LB; Handrich, C; Kreidenweiss, A; Kremsner, PG; Lell, B; Mombo-Ngoma, G; Ndzebe-Ndoumba, WF; Nordmann, T; Okwu, DG; Ramharter, M; Stelzl, D; Veletzky, L; Zoleko-Manego, R | 1 |
| Bhide, AR; Dighe, VD; Jindal, AB; Jirwankar, YB; Katnoria, S; Kaur, S; Suri, M | 1 |
| Augusto, O; Byamugisha, J; Clerk, C; Dellicour, S; Desai, M; Gomes, M; Guérin, PJ; Hill, J; Kagawa, M; Kariuki, S; Kisinza, W; Manyando, C; McGready, R; Mehta, U; Mosha, D; Mrema, S; Njunju, EM; Nosten, F; Rouamba, T; Rulisa, S; Saito, M; Sevene, E; Singlovic, J; Stepniewska, K; Stergachis, A; Ter Kuile, FO; Tinto, H; Vala, A; van Eijk, AM; Were, E; Yore, M | 1 |
| He, Z; Hu, J; Huang, Q; Li, X; Liang, J; Liao, X; Pan, Z; Ru, L; Song, J; Xu, Q; Yu, C; Yu, W; Zeng, F; Zhang, X | 1 |
| Adams, M; Buchwald, AG; Divala, TH; Earland, DE; Laufer, MK; Laurens, MB; Mallewa, JE; Miller, J; Mungwira, RG; Nampota-Nkomba, N; Nyangulu, W; Nyirenda, OM; Parikh, S; Plowe, CV; Taylor, TE; van Oosterhout, JJ | 1 |
| Mace, KE; Schultz, JS; Tan, KR | 1 |
| Adjei, GO; Ahorhorlu, SY; Alifrangis, M; Duah-Quashie, NO; Dzudzor, B; Hansson, H; Jensen, RW; Kudzi, W; Nartey, ET; Quashie, NB; Wang, CW; Zoiku, F | 1 |
| Batty, KT; Davis, TME; Kasian, B; Laman, M; Lorry, L; Manning, L; Moore, BR; Pomat, W; Robinson, LJ; Salman, S; Tesine, P; Woon, SA; Yadi, G; Yambo, P | 1 |
| Ashton, RA; Bennett, A; Burnett, S; Eisele, TP; Hainsworth, M; Hamainza, B; Lungu, C; Miller, JM; Porter, T; Rutagwera, MI; Silumbe, K; Slater, H | 1 |
| Abala, C; Nyeko, R; Obiya, EM; Otim, F | 1 |
| Bogoch, II; Halani, S | 1 |
| Ahmed, RA; Begum, A; Hussain, SSA; Kalita, D; Kumar, A; Kumar, G; Shankar, H; Singh, K; Suri, HS; Swargiary, A | 1 |
| Akala, HM; Amwoma, JG; Andagalu, BM; Chemwor, GC; Cheruiyot, AC; Egbo, TE; Garges, EC; Juma, DW; Juma, JA; Kamau, E; Mwakio, EW; Ogutu, BR; Okoth, RO; Onyango, IA; Opot, BH; Roth, AL; Wakoli, DM; Watson, OJ; Yedah, RA | 1 |
| Aygen, B; Kalın Ünüvar, G; Türe, Z; Yaman, O; Yıldız, O | 1 |
| Djissem, PE; Manyeh, AK; Tetteh, JA | 1 |
| Aina, O; Awolola, ST; Babatunde, S; David, AN; Ekama, SO; Happi, CT; Ijezie, SN; Mohammed, AB; Mokuolu, O; Musa, AZ; Ogbulafor, N; Oguche, S; Okafor, H; Olukosi, AY; Ozor, L; Salako, BL; Uhomoibhi, PE; Wammanda, R | 1 |
| Chepngetich, J; Gachie, B; Gathirwa, J; Kiboi, D; Kimani, F; Magoma, G; Muriithi, B; Mwitari, P; Onchieku, N; Thiong'o, K | 1 |
| Agyemang, SA; Aikins, M; Amon, S; Aryeetey, GC; Baabu, BS; Dwomoh, D; Malm, K; Nonvignon, J; Novignon, J; Owusu, R; Peprah, NY | 1 |
| Buzibye, A; Nakalembe, L; Nsobya, S; Ocan, M; Omali, D; Otike, C | 1 |
| Adebanjo, IM; Ademowo, OG; Ajayi, AM | 1 |
| Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jawara, A; Oboh, M; Oriero, E; Tadele, G | 1 |
| Adhikari, B; Callery, JJ; Cheah, PY; Conradis-Jansen, F; Dondorp, AM; Ean, M; Jongdeepaisal, M; Khonputsa, P; Maude, RJ; Müller, O; Murgia, R; Pell, C; Peto, TJ; Sovannaroth, S; Tripura, R; von Seidlein, L | 1 |
| Chikoto, H; Csermak, K; Demin, I; El Gaaloul, M; Fofana, B; Grobusch, MP; Kaguthi, G; Kibuuka, A; Kusemererwa, S; Lingani, M; Lourenço, C; Marrast, AC; Mehta, D; Mombo-Ngoma, G; N'Guessan, TL; Nassa, GJW; Nduba, V; Nyantaro, M; Ogutu, B; Pathan, R; Risterucci, C; Singh, PK; Su, G; Thompson, R; Tina, LO; Tinto, H; Toure, AO; Uthaisin, C; Verma, A; Winnips, C; Yeka, A | 1 |
| Bernieri, F; Cavallari, S; Doderer-Lang, C; Guidetti, C; L'Episcopia, M; Menard, D; Perrotti, E; Priuli, GB; Severini, C | 1 |
| Abel, L; Ambani, G; Boyce, M; Kirui, J; Laktabai, J; Malinga, J; Menya, D; Nalianya, E; Namae, J; O'Meara, W; Sang, E | 1 |
| Ayrık Demir, A; Erdoğan, E; Türe Yüce, Z; Yaman, O; Yıldız, O; Yürük, M | 1 |
| Aide, P; Baraka, V; Bassat, Q; Cousin, M; David, A; Gesase, S; Gwasupika, J; Hachizovu, S; Makenga, G; Manyando, C; Nhama, A; Ntizimira, CR; Obunge, O; Otsyula, N; Pathan, R; Risterucci, C; Su, G; Tshefu, KA | 1 |
| Bauserman, M; Laktabai, J; Rent, S; Taylor, SM; Tshefu, AK | 1 |
| Dellicour, S; Gutman, JR; Hill, J; Ochodo, E; Osoro, CB; Ter Kuile, F; Young, T | 1 |
| Dellicour, S; Gutman, JR; Hill, J; Ochodo, E; Osoro, CB; Ter Kuile, FO; Young, T | 1 |
| Ahmed, K; Culleton, R; Dony, JJF; Fornace, KM; Habil, B; Hassan, MR; Hod, R; Ibrahim, SSA; Jantim, A; Jeffree, MS; Jiee, SF; Mohamed, AFB; Naserrudin, NA | 1 |
| D'Alessandro, U; Dabira, ED; Diakite, H; Djimde, M; Dorlo, TP; Erhart, A; González, R; Kabore, B; Kayentao, K; Keita, M; Macuacua, S; Menendez, C; Mens, P; Muhindo, HM; Piqueras, M; Sagara, I; Schallig, H; Sevene, E; Tinto, H; Traore, M; Tshiongo, JK; Vala, A | 1 |
| Abade, A; O'Meara, WP; Odhiambo, F; Odhiambo, FO; Owiny, M; Oyugi, EO | 1 |
| Acharya, S; Arnold, L; Chico, RM; Gore-Langton, GR; Lufele, E; Moore, BR; Price, RN; Rogerson, SJ; Ter Kuile, FO; Thriemer, K; Unger, HW; van Eijk, AM; Wu, C | 1 |
| Angora, ÉK; Bedia-Tanoh, VA; Bosson-Vanga, H; Djohan, V; Kassi, FK; Kiki-Barro, PCM; Konaté-Touré, A; Koné-Bravo, EDM; Menan, HEI; Miezan, SAJ; Yavo, W | 1 |
| Ahoua Alou, LP; Camara, S; Koffi, AA; N'Guessan, B; N'Guessan, R; Oumbouke, WA; Rowland, M; Thomas, MB; Tia, IZ; Wolie, RZ; Zoh, MG | 1 |
| Abate, DT; Alam, MS; Anose, RT; Baird, JK; Christian, M; Degaga, TS; Ekawati, LL; Hailu, A; Hossain, MS; Karahalios, A; Kibria, MG; Kiros, FG; Lee, G; Ley, B; Mnjala, H; Panggalo, LV; Price, RN; Rajasekhar, M; Rumaseb, A; Sadhewa, A; Satyagraha, AW; Simpson, JA; Sutanto, I; Tego, TT; Thriemer, K; Weston, S; Woyessa, A | 1 |
| Aweeka, F; Huang, L; Hughes, E; Kajubi, R; Mwebaza, N; Mwima, MW; Nguyen, V; Nyunt, MM; Orukan, F; Parikh, S | 1 |
| Adegbola, AJ; Bolaji, OO; Hassan, IA; Onyeji, CO; Soyinka, JO | 1 |
| Clark, RL | 1 |
| Iribhogbe, OI; Odoya, EM | 1 |
| Al Khaja, KAJ; Sequeira, RP | 1 |
| Cargill, Z; Chu, C; Gilder, ME; McGready, R; Min, AM; Nosten, F; Phyo, AP; Poe, H; Saito, M; San, TD; White, NJ; Yotyingaphiram, W | 1 |
| Boateng-Marfo, Y; Dong, Y; Lin, HS; Ng, WK | 1 |
| Baguiya, A; Barry, N; Dianda, F; Héma, A; Hien, D; Kaboré, JMT; Kiba Koumaré, A; Kouanda, S; Nombré, Y; Savadogo, Y; Siribie, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB | 1 |
| Deng, C; Liang, Y; Lu, C; Song, J; Tan, B; Wang, Q; Wu, W; Xu, Q; Zhang, H; Zhou, C | 1 |
| Abba, T; Angora, EK; Assi, SB; Bedia, VA; Daho, AK; Emmanuel, B; Kiki-Barro, PMC; Konate, AA; Menan, H; Tiacoh, LN; Toure, OA; Yavo, W | 1 |
| Beshir, KB; Chijioke-Nwauche, I; Nwauche, CA; Oguike, MC; Sutherland, CJ | 1 |
| Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ | 1 |
| Dong, X; Gong, M; Gu, L; Li, J; Wang, M; Zhang, X | 1 |
| Baltzell, K; Benjamin-Chung, J; Bhangu, K; Dlamini, B; Dlamini, N; Dufour, MK; Gosling, R; Greenhouse, B; Helb, D; Hsiang, MS; Kalungero, M; Kunene, S; Malambe, C; Maphalala, G; Mngadi, N; Nhlabathi, N; Ntshalintshali, N; Pindolia, D; Prach, LM; Tesfa, G; Vilakati, S; Whittemore, B | 1 |
| Callery, JJ; Ean, M; Imwong, M; Maude, RJ; Mukaka, M; Peto, TJ; Sokha, M; Sovannaroth, S; Soviet, O; Tarning, J; Tripura, R; von Seidlein, L; Vongpromek, R; Waithira, N | 1 |
| Davis, TME; Davis, WA; Hii, KC; Page-Sharp, M; Salman, S; Singh, B; Sugiarto, SR | 1 |
| Achan, J; Biculu, J; Bukoma, P; Ediamu, T; Gudoi, S; Mulebeke, R; Musiime, A; Nantanda, R; Tibenderana, JK; Tumwine, D; Wanzira, H | 1 |
| Álvarez-Larrotta, C; Aponte, S; Bernal, SD; González, C; Guerra, ÁP; Knudson-Ospina, A; Restrepo, C; Yasnot, MF | 1 |
| Chow, SC; Yuan, M; Zheng, J | 1 |
| Alonso, S; Munguambe, K; Sicuri, E | 1 |
| Ahmad, FJ; Ali, S; Imam, SS; Jain, GK; Rahman, MA; Raisuddin, S; Shakeel, K | 1 |
| Grzesiak, M; Krekora, M; Respondek-Liberska, M; Słodki, M; Zych-Krekora, K | 1 |
| Antunes, LR; Grabe-Guimarães, A; Guimarães, HN; Mosqueira, VCF; Richard, S; Silveira, APA; Souza, ACM | 1 |
| César, IC; Fernandes, C; Pianetti, GA; Ricoy, LBM; Rivelli, GG | 1 |
| Gao, H; Kuang, X; Liu, H; Sun, J; Wang, Z; Yang, Y; Zhou, S | 1 |
| Bringmann, G; Feineis, D; Hoellein, L; Holzgrabe, U; Mufusama, JP; Ndjoko Ioset, K | 1 |
| Dias, S; Donegan, S; Welton, NJ | 1 |
| Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P | 1 |
| Bierhoff, M; Grobusch, MP; van Gool, T; van Hattem, JM; van Vugt, M; Visser, BJ | 1 |
| DeMasi, R; Kakuda, TN; Mohammed, P; van Delft, Y | 1 |
| Osonuga, A; Osonuga, AA; Osonuga, IO; Osonuga, OA | 1 |
| Adaramoye, OA; Ademowo, OG; Falade, CO; Nneji, CM | 1 |
| Pathak, S; Patil, S; Patravale, V; Sharma, S; Suryavanshi, S | 1 |
| Häussinger, D; Henrich, B; Holtfreter, MC; Imwong, M; Jensen, BO; Kocheril, SJ; MacKenzie, C; Mallach, S; Müller-Stöver, I; Orth, H; Richter, J; White, NJ | 1 |
| Conyers, RC; Mazzone, JR; Mott, BT; Posner, GH; Siegler, MA; Sullivan, DJ; Tripathi, AK | 1 |
| Abiodun, OO; Akinbo, J; Ojurongbe, O | 1 |
| Ba, BB; Boiron, JM; Fabre, JL; Fawaz, F; Gaubert, A; Gaudin, K; Grislain, L; Kauss, T; Lafarge, X; Lembege, M; Lindegardh, N; Marchivie, M; Millet, P; Olliaro, PL; White, NJ | 1 |
| Ademowo, OG; Dada-Adegbola, HO; Falade, CO; Nash, O; Oguike, MC; Ogunkunle, OO | 1 |
| Aditya, NP; Murthy, RS; Parashar, D | 1 |
| Adriko, M; Arinaitwe, M; Atuhaire, A; Betson, M; Kabatereine, NB; Mwesigwa, G; Nabonge, J; Sousa-Figueiredo, JC; Stothard, JR; Sutherland, CJ | 1 |
| Chen, T; Lu, T; Ma, Y; Mei, Q; Wang, Y; Zhao, W | 1 |
| Bruxvoort, K; Cairns, M; Festo, C; Goodman, C; Kachur, SP; Kalolella, A; Kenani, M; Lyaruu, P; Schellenberg, D | 1 |
| Ding, GY; Huang, JC; Li, XB; Shi, YX; Su, JK; Zheng, K | 1 |
| Abiodun, OO; Akinola, O; Badejo, JA; Gbotosho, GO; Happi, CT; Sowunmi, A | 1 |
| Emeje, M; Ezenyi, IC; Kulkarni, R; Salawu, OA | 1 |
| Corsello, MA; Garg, NK | 1 |
| Blagborough, AM; Brock, PM; Churcher, TS; Delves, MJ; Gething, PW; Ghani, AC; Leroy, D; Sala, KA; Sinden, RE; Upton, LM | 1 |
| Agubata, CO; Attama, AA; Mueller-Goymann, CC; Nzekwe, IT; Onunkwo, GC | 1 |
| Bendel, D; Davis, TM; Lee, TC; Salman, S; Templeton, D | 1 |
| Diarra, A; Siribié, M; Sirima, SB; Soulama, I; Tiono, AB | 1 |
| Aklillu, E; Kamuhabwa, AA; Maganda, BA; Minzi, OM; Ngaimisi, E | 1 |
| Jones, C; Okiro, EA; Snow, RW; Todd, J; Wasunna, B; Webster, J | 1 |
| Acheampong, PR; Antwi, GD; Bart Plange, C; Cairns, M; Chandramohan, D; Tagbor, H | 1 |
| Kakoko, D; Simba, D | 1 |
| Cohen, J; Kasozi, H; Saran, I; Yavuz, E | 1 |
| Chen, A; Gallien, J; Leung, NH; Yadav, P | 1 |
| de Jager, C; Hongoro, C; Longwe, H; Mutero, CM; Mwendera, C; Phiri, K | 1 |
| Awale, M; Jain, SA; Pathak, S; Patravale, VB; Sharma, S; Vanage, G | 1 |
| Pathak, S; Patravale, V; Prabhu, P; Sharma, S; Suryavanshi, S | 1 |
| Awano, T; Baba, ES; Batisso, E; Edossa, W; Getachew, D; Hamade, P; Kebede, Z; Kefyalew, T; Mekonnen, E; Mukanga, D; Nankabirwa, JI; Shumba, C; Tekalegne, A; Tibenderana, J | 1 |
| Allan, R; Floridia, M; Fortes, F; Lussiana, C; Martinho do Rosário, J | 1 |
| Bekkali, H; Belkouch, A; Belyamani, L; Jidane, S; Zidouh, S | 1 |
| Desai, P; Dhumatkar, R; Gaud, RS; Shende, P | 1 |
| Sullivan, DJ; Walker, LA | 1 |
| Adjuik, M; Amenga-Etego, S; Asante, KP; Chandramohan, D; Dosoo, DK; Greenwood, B; Gyapong, J; Owusu, R; Owusu-Agyei, S | 1 |
| Joshi, M; Pathak, S; Patravale, V; Sharma, S | 2 |
| Mandawgade, SD; Pathak, S; Patravale, VB; Sharma, S | 1 |
| Meek, S; Nankabirwa, J; Njogu, JN; Rwakimari, JB; Snow, RW; Ssekitooleko, J; Talisuna, A; Tibenderana, JK; Zurovac, D | 1 |
| Barennes, H; Dembele, EM; Diakite, C; Diallo, D; Dicko, M; Falquet, J; Forster, M; Giani, S; Graz, B; Lambert, B; Willcox, ML | 1 |
| Dorsey, G; Nosten, F; Price, RN | 1 |
| Campagna, AM; Patnaik, MM | 1 |
| Banura, P; Jacob, ST; Kenya-Mugisha, N; Mayanja-Kizza, H; Meya, DB; Moore, CC; Pinkerton, R; Reynolds, SJ; Scheld, WM | 1 |
| Thompson, CA | 1 |
| Aweeka, FT; Huang, L; Jayewardene, AL; Li, X; Lizak, PS; Marzan, F | 1 |
| Amos, B; Hendriksen, I; Mandea, V; Manjurano, A; Mapunda, E; Mrema, H; Mtove, G; Reyburn, H; Rutta, B; Sykes, A; Whitty, CJ | 1 |
| Bacchieri, A; Bassat, Q; Borrmann, S; Corsi, M; D'Alessandro, U; Menéndez, C; Mulenga, M; Nabasumba, C; Nambozi, M; Piola, P; Sasi, P; Talisuna, A; Tinto, H; Ubben, D; Valéa, I | 1 |
| Efferth, T; Kaina, B | 1 |
| Aditya, NP; Madhusudhan, B; Murthy, RS; Patankar, S; Souto, EB | 1 |
| Clark, TD; Dorsey, G; Greenhouse, B; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG | 1 |
| Arinaitwe, E; Bigira, V; Creek, D; Dorsey, G; Kakuru, A; Kamya, MR; Sandison, TG; Tappero, J; Wanzira, H | 1 |
| Anstey, NM; Chan, L; Donaldson, S; Frederick, C; Jelip, J; Khoo, S; Ma, G; Menon, J; Rajahram, G; William, T; Yeo, TW | 1 |
| Chin, LC; Fong, MY; Lau, YL; Noraishah, MA; Rohela, M; Tan, LH | 1 |
| Davis, TM; Griffin, S; Ilett, KF; Kose, K; Mueller, I; Page-Sharp, M; Salman, S; Siba, PM | 1 |
| Arguin, PM; Doney, AC; Galev, A; Green, M; Kapella, BK; Mekonnen, L; Phares, CR; Stauffer, WM; Weinberg, M | 1 |
| Denholm, J; Shortt, J; Smith, A; Spelman, D | 1 |
| Franken, G; Häussinger, D; Holtfreter, MC; Labisch, A; Mehlhorn, H; Müller-Stöver, I; Richter, J; Walter, S | 1 |
| Joshi, M; Pathak, S; Patil, S; Patravale, V; Sharma, S | 1 |
| Gettayacamin, M; Kyle, DE; Li, QG; Milhous, WK; Mog, SR; Si, YZ | 1 |
| Kager, PA | 1 |
| Marsh, K | 1 |
| Brasseur, P; Chippaux, JP; Garcia, A; Le Hesran, JY | 1 |
| Afzal, K; Ali, SM; Huda, SN; Khan, HM; Shahab, T | 1 |
| Cai, Y; Chollet, J; Tanner, M; Utzinger, J; Xiao, SH; Yao, JM | 1 |
| Arai, M; Ishii, A; Matsuoka, H | 1 |
| Gamble, C; Garner, P; Omari, AA | 1 |
| Bégué, JP; Bonnet-Delpon, D; Charneau, S; Crousse, B; Grellier, P; Magueur, G | 1 |
| Majori, G | 1 |
| Stingl, P | 1 |
| Garner, P; Omari, A | 4 |
| Guo, J; Ni, YC; Wang, QM; Wu, JT | 1 |
| Ansah, E; Reyburn, H; Whitty, CJ | 1 |
| Chan, HW; Gerena, L; Haynes, RK; Ho, WY; Ko, CK; Kyle, DE; Peters, W; Robinson, BL | 1 |
| Balasegaram, M; Davidson, R; Dejene, S; Perkins, S; Tinnemann, P | 1 |
| Arunkamomkiri, J; Ashley, E; Carrara, VI; Htoo, H; Hutagalung, R; Nosten, F; Nwee, P; Singhasivanon, P; White, NJ; Zwang, J | 1 |
| Chollet, J; Shu-Hua, X; Tanner, M; Utzinger, J | 1 |
| Chinbuah, AM; Gyapong, JO; Gyapong, M; Pagnoni, F; Wellington, EK | 1 |
| Alecrim, Md; Alecrim, WD; Boulos, M; Cardoso, B; de Lacerda, MV; Mourão, MP; Padilha, A | 1 |
| Akhwale, W; Larson, BA; Snow, RW; Zurovac, D | 1 |
| Chollet, J; Santo-Tomas, J; Scheurer, C; Snyder, C; Wittlin, S | 1 |
| Adeoshun, IO; Akanji, BO; Akomolafe, RO; Ayoka, AO; Fakunle, JB; Iwalewa, EO | 1 |
| Davis, TM; Ilett, KF; Karunajeewa, HA; Manning, L; Mueller, I | 1 |
| Nyunt, MM; Plowe, CV | 1 |
| Agbodjan-Djossou, A; Azoumah, KD; Balaka, B; Djadou, D; Djadou, KE; Komlangan, A; Lawson-Evi, K | 1 |
| Hopkins, H; Lubell, Y; Mills, A; Staedke, SG; Whitty, CJ | 1 |
| Goodman, CA; Snow, RW; Wasunna, B; Zurovac, D | 1 |
| Ahmadi, M; El-Bahnasawy, M; Gouda, H; Ibrahim, A; Shahat, SA; Zaher, T | 1 |
| Kuhn, T; Wang, Y | 1 |
| Chen, LJ; Gu, HM; Ji, RY; Liu, MZ; Lu, BF; Sun, WK; Wang, MY; Xu, B; Xu, JY | 1 |
| Chen, KY; Lin, BY; Ye, XY; Zhang, JX; Zheng, H | 1 |
| Guo, XB; Jian, HX; Jin, R; Li, GQ; Li, ZY; Wang, ZC | 1 |
| Li, GQ | 1 |
| Boecken, GH; Lademann, M | 1 |
| Ager, AL; Klayman, DL; Lin, AJ | 1 |
| Chen, YD; Lin, BY; Pan, YR; Tang, WZ; Xu, B; Zhang, JX; Zheng, H | 1 |
| Fang, Y; Lin, BY; Pan, YR; Zhang, JX; Zheng, H | 1 |
| Ager, AL; Canfield, CJ; Heiffer, MH; Klayman, DL; Kyle, DE; Milhous, WK; Rossan, RN; Schuster, BG; Shmuklarsky, MJ; Tang, DB | 1 |
| Ambroise-Thomas, P | 2 |
| Ezzet, F; Karbwang, J; Mull, R | 1 |
| Ernst, E; Pittler, MH | 1 |
| Boele van Hensbroek, M | 1 |
| Nosten, F; van Vugt, M; White, NJ | 1 |
| Ezzet, F; van Vugt, M; White, NJ | 1 |
| Takeuchi, T | 1 |
| MacDonald, RD | 1 |
| Ishiyama, A; Kohana, A; Manabe, C; Omura, S; Otoguro, K; Shiomi, K; Ui, H; Yamada, H | 1 |
| Bringmann, G; Chimanuka, B; François, G; Heyden, YV; Holenz, J; Plaizier-Vercammen, J; Timperman, G | 1 |
| Chimanuka, B; Detaevernier, MR; Gabriëls, M; Plaizier-Vercammen, JA | 1 |
| Wang, TY | 1 |
| Li, XY; Liang, HZ | 1 |
| Cai, Y; Li, AY; Xie, PS; Xuan, WY; Zhao, Y | 1 |
| Pang, XJ | 1 |
| Feng, TG; Guo, XB; Li, GQ; Li, PS; Shi, WZ; Wang, HF; Zhang, SF | 1 |
| Du, YL; Jiang, Q; Li, CS | 1 |
| Li, ZL; Peters, W; Robinson, BL; Warhurst, DC | 1 |
| Gu, HM; Waki, S; Zhu, MY | 1 |
| Cai, XZ; He, XZ; Yang, XP; Ye, BS; Zhan, WC; Zhan, X | 1 |
| Wang, TY; Xu, RC | 1 |
26 review(s) available for artemether and Malaria
| Article | Year |
|---|---|
Recent advances in malaria drug discovery.
Topics: Animals; Antimalarials; Drug Discovery; Humans; Liver; Liver Transplantation; Malaria; Molecular Structure | 2013 |
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum | 2022 |
Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.
Topics: Abortion, Spontaneous; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Quinine; Stillbirth | 2023 |
The effect and control of malaria in pregnancy and lactating women in the Asia-Pacific region.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Asia; Female; Humans; Lactation; Malaria; Malaria, Falciparum; Pregnancy | 2023 |
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Combinations; Female; Humans; Malaria; Parasitemia; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinine; Sulfadoxine | 2021 |
Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance, Microbial; Malaria; Molecular Structure; Plasmodium falciparum | 2015 |
Toxicity of the antimalarial artemisinin and its dervatives.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Clinical Trials as Topic; Developing Countries; Dogs; Drug Administration Routes; Drug-Related Side Effects and Adverse Reactions; Humans; Malaria; Rabbits; Rats; Sesquiterpenes | 2010 |
[Three newly registered drugs in the Netherlands for the treatment and chemoprophylaxis of malaria: atovaquone-proguanil, artemether-lumefantrine and artemotil].
Topics: Antimalarials; Artemether; Artemisinins; Atovaquone; Drug Approval; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Naphthoquinones; Netherlands; Proguanil; Sesquiterpenes; Treatment Outcome | 2003 |
Artemesinins for severe malaria in Africa?
Topics: Adult; Antimalarials; Artemether; Artemisia; Artemisinins; Child; Drug Evaluation; Humans; Malaria; Phytotherapy; Sesquiterpenes | 2002 |
Artemether-lumefantrine for uncomplicated malaria: a systematic review.
Topics: Antimalarials; Artemether; Artemisinins; Drug Administration Schedule; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Parasitemia; Randomized Controlled Trials as Topic; Sesquiterpenes; Treatment Outcome | 2004 |
[Combined antimalarial therapy using artemisinin].
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Doxycycline; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Plasmodium; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2004 |
[Malaria: prophylaxis, treatment, stand-by medication. A single mosquito bite suffices].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Atovaquone; Chloroquine; Climate; Doxycycline; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Mefloquine; Naphthoquinones; Pregnancy; Proguanil; Risk Factors; Self Medication; Sesquiterpenes; Time Factors; Travel | 2004 |
Malaria in endemic areas.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Chloroquine; Deferoxamine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2003 |
Malaria: severe, life threatening.
Topics: Antimalarials; Artemether; Artemisinins; Blood Transfusion; Humans; Malaria; Malaria, Falciparum; Quinine; Sesquiterpenes | 2004 |
Malaria: severe, life threatening.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Humans; Malaria; Quinine; Sesquiterpenes | 2004 |
Malaria: severe, life threatening.
Topics: Acute Disease; Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria; Quinine; Sesquiterpenes | 2006 |
Rectal administration of artemisinin derivatives for the treatment of malaria.
Topics: Administration, Rectal; Area Under Curve; Artemether; Artemisinins; Artesunate; Humans; Malaria; Sesquiterpenes | 2007 |
Artemisinin--an innovative cornerstone for anti-malaria therapy.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisia annua; Artemisinins; Biomass; Crops, Agricultural; Drug Combinations; Drug Design; Drug Resistance; Drugs, Chinese Herbal; Ethanolamines; Fluorenes; Humans; Malaria; Models, Molecular; Molecular Structure; Technology, Pharmaceutical; Treatment Outcome | 2008 |
[Intra-muscular artemether in the treatment of severe malaria: synthesis of current results].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Child; Drug Resistance; Humans; Infusions, Intravenous; Injections, Intramuscular; Malaria; Quinine; Research Design; Sesquiterpenes; Survival Analysis; Treatment Outcome | 1997 |
Artemether for severe malaria: a meta-analysis of randomized clinical trials.
Topics: Antimalarials; Artemether; Artemisinins; Humans; Malaria; Odds Ratio; Quinine; Sesquiterpenes | 1999 |
The role of the qinghaosu derivatives in the treatment of severe malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Child; Humans; Malaria; Quinine; Research Design; Sesquiterpenes | 1998 |
Intrarectal artemisinin derivatives.
Topics: Absorption; Administration, Rectal; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Humans; Malaria; Metabolic Clearance Rate; Sesquiterpenes; Suppositories | 1998 |
Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethanolamines; Fluorenes; Food-Drug Interactions; Humans; Lumefantrine; Malaria; Plasmodium falciparum; Sesquiterpenes | 1999 |
[Treatment of malaria: prevention of resistance by combinations of antimalarial agents].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Naphthyridines; Plasmodium; Sesquiterpenes | 2000 |
[Malaria].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Diagnosis, Differential; Humans; Malaria; Prognosis; Sesquiterpenes | 2001 |
41 trial(s) available for artemether and Malaria
| Article | Year |
|---|---|
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Recurrence; Vomiting | 2022 |
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines | 2022 |
Safety, Tolerability, and Parasite Clearance Kinetics in Controlled Human Malaria Infection after Direct Venous Inoculation of Plasmodium falciparum Sporozoites: A Model for Evaluating New Blood-Stage Antimalarial Drugs.
Topics: Adult; Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Parasitemia; Parasites; Plasmodium falciparum; Sporozoites | 2022 |
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Parasitemia; Prospective Studies; Reinfection; Uganda | 2023 |
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cambodia; Chemoprevention; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum | 2023 |
Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chemoprevention; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum | 2022 |
Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Gabon; Humans; Malaria; Malaria, Falciparum; Schistosomiasis haematobia | 2022 |
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Treatment Outcome | 2023 |
Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium vivax; Primaquine; Time-to-Treatment | 2023 |
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Kenya; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Reinfection; Retrospective Studies | 2023 |
Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Female; Forests; Humans; Malaria | 2023 |
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome | 2023 |
Supply-side and demand-side factors influencing uptake of malaria testing services in the community: lessons for scale-up from a post-hoc analysis of a cluster randomised, community-based trial in western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Community Health Services; Community Health Workers; Fever; Humans; Kenya; Malaria; Research Design | 2023 |
Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Humans; Infant; Malaria; Malaria, Falciparum; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Sub-Saharan African People; Treatment Outcome | 2023 |
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Australia; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Primaquine | 2023 |
Randomized Controlled Trial of the Electrocardiographic Effects of Four Antimalarials for Pregnant Women with Uncomplicated Malaria on the Thailand-Myanmar Border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Therapy, Combination; Electrocardiography; Female; Humans; Malaria; Malaria, Falciparum; Myanmar; Pregnancy; Pregnant Women; Quinolines; Thailand | 2021 |
Efficacy and safety of artesuante-amodiaquine and artemether lumefantrine, the first line malaria treatment in six sentinel's sites of Côte d'Ivoire, West Africa.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cote d'Ivoire; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria; Malaria, Falciparum; Treatment Outcome | 2020 |
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand | 2021 |
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Eswatini; Humans; Malaria; Mass Drug Administration; Quinolines | 2021 |
Study protocol: an open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cambodia; Forests; Humans; Malaria; Malaria, Falciparum; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
Topics: Adult; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Cross-Over Studies; Darunavir; Drug Interactions; Ethanolamines; Fluorenes; Healthy Volunteers; HIV; HIV Infections; Humans; Lumefantrine; Malaria; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Ritonavir; Sulfonamides | 2013 |
Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children.
Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chlorpheniramine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Genome, Protozoan; Humans; Infant; Lumefantrine; Malaria; Male; Nigeria; Polymerase Chain Reaction | 2014 |
Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Commerce; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria; Male; Patient Compliance; Plasmodium; Tanzania; Text Messaging | 2014 |
Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in African children with malaria.
Topics: Administration, Sublingual; Africa; Antimalarials; Artemether; Artemisinins; Child, Preschool; Female; Humans; Infant; Malaria; Male | 2015 |
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Pyrimethamine; Quinolines; Rain; Seasons; Sulfadoxine | 2016 |
Can Rapid Diagnostic Testing for Malaria Increase Adherence to Artemether-Lumefantrine?: A Randomized Controlled Trial in Uganda.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Medication Adherence; Point-of-Care Testing; Uganda | 2016 |
An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Dapsone; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Polymerase Chain Reaction; Proguanil; Treatment Outcome | 2008 |
Sublingual sugar for hypoglycaemia in children with severe malaria: a pilot clinical study.
Topics: Administration, Sublingual; Adolescent; Antimalarials; Artemether; Artemisinins; Blood Glucose; Child; Child, Preschool; Female; Glucose; Humans; Hypoglycemia; Infant; Infusions, Intravenous; Injections, Intramuscular; Malaria; Male; Mali; Pilot Projects; Rural Health; Treatment Outcome | 2008 |
Treatment of severe sepsis with artemether-lumefantrine is associated with decreased mortality in Ugandan patients without malaria.
Topics: Adult; Anti-Infective Agents; Artemether; Artemisinins; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Prospective Studies; Sepsis; Uganda; Young Adult | 2009 |
Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Azithromycin; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Female; Fever of Unknown Origin; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Tanzania; Treatment Outcome | 2009 |
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
Topics: Africa; Antiparasitic Agents; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Time Factors | 2009 |
Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Incidence; Infant; Lumefantrine; Malaria; Male; Pyrimethamine; Sulfadoxine; Treatment Outcome; Uganda | 2010 |
Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Quinolines; Risk; Uganda; Vomiting | 2010 |
Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male | 2011 |
A comparative clinical trial of artemether and quinine in children with severe malaria.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria; Male; Prospective Studies; Quinine; Sesquiterpenes; Survival Analysis; Treatment Outcome | 2003 |
Antimalarial efficacy and mode of action of qinghaosu and its derivatives in experimental models. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Erythrocytes; Malaria; Mice; Multicenter Studies as Topic; Plasmodium; Sesquiterpenes | 1982 |
Clinical studies on the treatment of malaria with qinghaosu and its derivatives. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Humans; Malaria; Multicenter Studies as Topic; Plasmodium falciparum; Plasmodium vivax; Sesquiterpenes | 1982 |
Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Sesquiterpenes; Treatment Outcome | 1998 |
Artemether for severe malaria: a meta-analysis of randomized clinical trials.
Topics: Antimalarials; Artemether; Artemisinins; Humans; Malaria; Odds Ratio; Quinine; Sesquiterpenes | 1999 |
The effect of mefloquine-artemether compared with quinine on patients with complicated falciparum malaria.
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Quinine; Quinolines; Sesquiterpenes | 1988 |
A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Clinical Trials as Topic; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Pyrans; Quinine; Sesquiterpenes; Time Factors | 1987 |
177 other study(ies) available for artemether and Malaria
| Article | Year |
|---|---|
Arteether, a new antimalarial drug: synthesis and antimalarial properties.
Topics: Animals; Antimalarials; Artemisinins; Magnetic Resonance Spectroscopy; Malaria; Mice; Models, Molecular; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes | 1988 |
Synthesis and antimalarial activities of fluoroalkyl derivatives of dihydroartemisinin.
Topics: Animals; Antimalarials; Artemisinins; Drug Evaluation, Preclinical; Female; Inhibitory Concentration 50; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1998 |
Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5. 2]hexadecanes.
Topics: Alkanes; Animals; Antimalarials; Malaria; Mice; Neurites; Neuroblastoma; Plasmodium berghei; Plasmodium falciparum; Spiro Compounds; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in vivo metabolism of novel, potent C-10-phenoxy derivatives of dihydroartemisinin.
Topics: Animals; Antimalarials; Artemisinins; Bile; Crystallography, X-Ray; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Free Radicals; Malaria; Male; Mice; Phenyl Ethers; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Rats; Rats, Wistar; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship | 2001 |
Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues.
Topics: Animals; Antimalarials; Artemisinins; Heterocyclic Compounds, 4 or More Rings; Malaria; Male; Mice; Piperazines; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes | 2002 |
A short synthesis and biological evaluation of potent and nontoxic antimalarial bridged bicyclic beta-sulfonyl-endoperoxides.
Topics: Animals; Antimalarials; Bridged Bicyclo Compounds, Heterocyclic; Malaria; Male; Mice; Mice, Inbred ICR; Plasmodium berghei; Plasmodium falciparum; Stereoisomerism; Structure-Activity Relationship; Sulfones | 2003 |
Orally active antimalarials: hydrolytically stable derivatives of 10-trifluoromethyl anhydrodihydroartemisinin.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Biological Availability; Drug Resistance; Drug Stability; Heterocyclic Compounds, 4 or More Rings; Hydrolysis; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship | 2004 |
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes.
Topics: Adamantane; Animals; Antimalarials; Cell Line, Tumor; Drug Resistance; Half-Life; Malaria; Malaria, Falciparum; Mice; Micronucleus Tests; Ozone; Peroxides; Plasmodium berghei; Rats; Spiro Compounds; Structure-Activity Relationship | 2005 |
Antimalarial activity of N-alkyl amine, carboxamide, sulfonamide, and urea derivatives of a dispiro-1,2,4-trioxolane piperidine.
Topics: Amines; Animals; Antimalarials; Humans; Malaria; Mice; Microsomes, Liver; Piperidines; Plasmodium berghei; Sulfonamides; Urea | 2006 |
Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
Topics: Animals; Antimalarials; Biological Transport; Cell Line, Tumor; Chloroquine; Drug Resistance; Drug Therapy, Combination; Glutathione Reductase; Humans; In Vitro Techniques; Malaria; Mice; Mice, Inbred BALB C; Naphthalenes; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2008 |
Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells.
Topics: Administration, Oral; Animals; Antimalarials; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Stability; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Mice; Sulfones | 2009 |
Spiroindolones, a potent compound class for the treatment of malaria.
Topics: Adenosine Triphosphatases; Animals; Antimalarials; Cell Line; Drug Discovery; Drug Resistance; Erythrocytes; Female; Genes, Protozoan; Humans; Indoles; Malaria; Male; Mice; Models, Molecular; Mutant Proteins; Mutation; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Protein Synthesis Inhibitors; Protozoan Proteins; Rats; Rats, Wistar; Spiro Compounds | 2010 |
Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Topics: Administration, Oral; Animals; Antimalarials; Atovaquone; Crystallography, X-Ray; Cytochromes b; Drug Design; Drug Resistance; Humans; Malaria; Male; Mice; Microsomes, Liver; Models, Molecular; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Pyridines; Quinolones; Quinone Reductases; Rats; Structure-Activity Relationship | 2012 |
Antimalarial chemotherapy: orally curative artemisinin-derived trioxane dimer esters.
Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Dimerization; Malaria; Mice; Plasmodium berghei | 2015 |
Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005-2018.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ghana; Humans; Infant; Malaria; Malaria, Falciparum; Treatment Failure | 2021 |
Implementation of community case management of malaria in malaria endemic counties of western Kenya: are community health volunteers up to the task in diagnosing malaria?
Topics: Adult; Aged; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Case Management; Community Health Workers; Diagnostic Tests, Routine; Female; Humans; Kenya; Malaria; Middle Aged; Public Health; Volunteers | 2022 |
School-Based Malaria Screening and Treatment Reduces Plasmodium falciparum Infection and Anemia Prevalence in Two Transmission Settings in Malawi.
Topics: Anemia; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Humans; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Prevalence; Prospective Studies; Schools | 2022 |
Plasmodium malariae after successful treatment of P. falciparum malaria with artemether-lumefantrine.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Fluorenes; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Plasmodium malariae | 2022 |
Health care provider practices in diagnosis and treatment of malaria in rural communities in Kisumu County, Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Diagnostic Tests, Routine; Fever; Health Personnel; Humans; Kenya; Malaria; Malaria, Falciparum; Real-Time Polymerase Chain Reaction; Rural Population; Sensitivity and Specificity | 2022 |
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Chloroquine; DNA Copy Number Variations; Female; Humans; Liberia; Malaria; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Pregnancy | 2022 |
Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Congo; Drug Combinations; Fever; Humans; Malaria; Parasitemia; Prevalence | 2022 |
Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Malaria; Malaria, Falciparum; Mutation; Parasites; Plasmodium falciparum; Prevalence; Protozoan Proteins; Uganda | 2022 |
[Monitoring the Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Central African Republic; Child; Cross-Sectional Studies; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Mutation; Treatment Outcome | 2021 |
The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children.
Topics: Anemia, Sickle Cell; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Tanzania | 2022 |
Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Burkina Faso; Child; Cross-Sectional Studies; Female; Fever; Humans; Malaria; Patient Acceptance of Health Care; Pregnancy | 2022 |
Cost-Utility Analysis of Community Case Management for Malaria Control in Burundi.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Burundi; Case Management; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Malaria | 2022 |
Controlled release starch-lipid implant for the therapy of severe malaria.
Topics: Artemether; Delayed-Action Preparations; Humans; Lactic Acid; Lipids; Malaria; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Starch | 2022 |
Multiple Plasmodium falciparum drug resistance polymorphisms identified in a pregnant woman with severe malaria and a concomitant spontaneous abortion in Cross River, Nigeria, West Africa.
Topics: Abortion, Spontaneous; Adult; Africa, Western; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Drug Resistance, Multiple; Female; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pregnancy; Pregnant Women; Quinine | 2022 |
Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.
Topics: Adult; Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Healthy Volunteers; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Sporozoites | 2023 |
Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Burkina Faso; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Naphthyridines | 2022 |
Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Humans; Kenya; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum | 2023 |
Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Gambia; Ligands; Lumefantrine; Malaria; Malaria, Falciparum; Merozoites; Plasmodium falciparum; Protozoan Proteins | 2022 |
Persistence of Residual Submicroscopic P. falciparum Parasitemia following Treatment of Artemether-Lumefantrine in Ethio-Sudan Border, Western Ethiopia.
Topics: Adolescent; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Disease Progression; Ethanolamines; Ethiopia; Fluorenes; Humans; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Sudan; Treatment Outcome | 2022 |
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Folic Acid Antagonists; Humans; Infant; Kenya; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines; Reinfection | 2022 |
Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Tanzania; Treatment Outcome | 2022 |
High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Genotype; Health Facilities; Humans; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Prevalence; Protozoan Proteins | 2022 |
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; HIV Infections; Humans; Lopinavir; Lumefantrine; Malaria; Malaria, Falciparum; Nevirapine; Ritonavir; Uganda | 2023 |
Plasmodium falciparum community prevalence and health-seeking behaviours in rural Sussundenga District, Mozambique.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Humans; Malaria; Malaria, Falciparum; Mozambique; Patient Acceptance of Health Care; Plasmodium falciparum; Prevalence | 2022 |
Evaluation of Pharmacokinetics, Biodistribution, and Antimalarial Efficacy of Artemether-Loaded Polymeric Nanorods.
Topics: Animals; Antimalarials; Artemether; Malaria; Mice; Nanotubes; Rats; Tissue Distribution | 2023 |
Erythrocyte membrane with CLIPPKF as biomimetic nanodecoy traps merozoites and attaches to infected red blood cells to prevent Plasmodium infection.
Topics: Animals; Artemether; Biomimetics; Erythrocyte Membrane; Erythrocytes; Malaria; Merozoites; Mice; Mice, Inbred C57BL; Phosphatidylserines; Plasmodium berghei; Plasmodium falciparum | 2023 |
Return to Travel in the Coronavirus Disease 2019 Pandemic Recovery Period and Implications for Imported Malaria: Reinforcing Prevention, Early Diagnosis, and Appropriate Treatment of Malaria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; COVID-19; COVID-19 Testing; Early Diagnosis; Humans; Malaria; Malaria, Falciparum; Pandemics; Travel; United States | 2023 |
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Tolerance; Ghana; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum | 2023 |
Effectiveness of community case management of malaria on severe malaria and inpatient malaria deaths in Zambia: a dose-response study using routine health information system data.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Case Management; Child; Community Health Workers; Health Information Systems; Humans; Inpatients; Malaria; Retrospective Studies; Zambia | 2023 |
Anti-malarial drug use, appropriateness and associated factors among children under-five with febrile illnesses presenting to a tertiary health facility: a cross sectional study.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Fever; Humans; Malaria | 2023 |
Weight-related malaria treatment failure with artemether-lumefantrine.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Treatment Failure | 2023 |
Impact assessment of Intensified Malaria Control Project in transitioning a high malaria-endemic district to a low-endemic district: an epidemiological aspect.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax | 2023 |
[Domestic Malaria Cases in Kayseri Province].
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Parasitemia; Travel | 2023 |
Prevalence, trends and associated factors of malaria in the Shai-Osudoku District Hospital, Ghana.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Cross-Sectional Studies; Ghana; Hospitals, District; Humans; Infant; Malaria; Malaria, Falciparum; Middle Aged; Prevalence; Young Adult | 2023 |
Design, Implementation, and Coordination of Malaria Therapeutic Efficacy Studies in Nigeria in 2018.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Nigeria | 2023 |
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Kenya; Lumefantrine; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Quinolines; Reinfection | 2023 |
Cost of inappropriate prescriptions for uncomplicated malaria in Ghana.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Ghana; Humans; Inappropriate Prescribing; Malaria; Retrospective Studies | 2023 |
Pharmacopeial quality of artemether-lumefantrine anti-malarial agents in Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Uganda | 2023 |
Vitamin C-rich juice co-administration with artemether-lumefantrine ameliorates oxido-inflammatory responses in Plasmodium berghei-infected mice.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Ascorbic Acid; Interleukin-6; Malaria; Malondialdehyde; Mice; Parasitemia; Plasmodium berghei; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |
Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2023 |
Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Benin; Drug Combinations; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2023 |
[A Marginal Case of Malaria: An Interesting Malaria Story of Cameroon Origin].
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cameroon; Coinfection; Humans; Malaria; Malaria, Vivax; Male; Middle Aged; Plasmodium; Plasmodium falciparum; Plasmodium vivax; Real-Time Polymerase Chain Reaction | 2023 |
Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Prescriptions; Prospective Studies; Tanzania; World Health Organization | 2023 |
Malaria in Pregnancy: Key Points for the Neonatologist.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Female; Humans; Infant; Infant, Newborn; Malaria; Neonatologists; Pregnancy; Premature Birth | 2023 |
Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Case Management; Cross-Sectional Studies; Female; Humans; Kenya; Malaria; Pregnancy; Quinine | 2023 |
Perceptions and drivers of healthcare provider and drug dispenser practices for the treatment of malaria in pregnancy in the context of multiple first-line therapies in western Kenya: a qualitative study.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Female; Health Personnel; Humans; Kenya; Malaria; Pharmaceutical Preparations; Pregnancy; Quinine | 2023 |
The public health response to a Plasmodium malariae outbreak in Penampang district, Sabah during a COVID-19 movement control order.
Topics: Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; COVID-19; Disease Outbreaks; Female; Humans; Malaria; Malaysia; Male; Mosquito Vectors; Pandemics; Plasmodium knowlesi; Plasmodium malariae; Public Health | 2023 |
Adherence to national malaria treatment guidelines in private drug outlets: a cross-sectional survey in the malaria-endemic Kisumu County, Kenya.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Fever; Humans; Kenya; Malaria; Surveys and Questionnaires | 2023 |
Knowledge and practices of private pharmacy auxiliaries on malaria in Abidjan, Côte d'Ivoire.
Topics: Antimalarials; Artemether; Cote d'Ivoire; Cross-Sectional Studies; Drug Combinations; Female; Humans; Lumefantrine; Malaria; Pharmacies; Pharmacy; Pregnancy; Surveys and Questionnaires | 2023 |
Attractive targeted sugar bait: the pyrrole insecticide chlorfenapyr and the anti-malarial pharmaceutical artemether-lumefantrine arrest Plasmodium falciparum development inside wild pyrethroid-resistant Anopheles gambiae s.s. mosquitoes.
Topics: Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Carbohydrates; Female; Humans; Insecticide Resistance; Insecticides; Malaria; Malaria, Falciparum; Male; Mosquito Control; Mosquito Vectors; Plasmodium falciparum; Pyrethrins; Sugars | 2023 |
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Pregnancy; Prospective Studies; Uganda; Young Adult | 2020 |
Post-Marketing Surveillance of Quality of Artemether Injection Marketed in Southwest Nigeria.
Topics: Antimalarials; Artemether; Cross-Sectional Studies; Geography; Humans; Injections; Malaria; Nigeria; Product Surveillance, Postmarketing | 2020 |
Teratogen update: Malaria in pregnancy and the use of antimalarial drugs in the first trimester.
Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Female; Malaria; Placenta; Pregnancy; Rabbits; Rats; Teratogens | 2020 |
Self-medication practice with antimalarials & the determinants of malaria treatment-seeking behavior among postpartum mothers in a rural community in Nigeria.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Female; Humans; Infant, Newborn; Malaria; Mothers; Nigeria; Postpartum Period; Rural Population | 2021 |
Artemether-Loaded Zein Nanoparticles: An Innovative Intravenous Dosage Form for the Management of Severe Malaria.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Caseins; Delayed-Action Preparations; Malaria; Nanoparticles; Rats; Rats, Sprague-Dawley; Zein | 2021 |
Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso.
Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Feasibility Studies; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy | 2021 |
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Electrocardiography; Humans; Malaria; Malaria, Falciparum; Quinolines | 2021 |
Antimalarial drug resistance markers in human immunodeficiency virus (HIV)-positive and HIV-negative adults with asymptomatic malaria infections in Port Harcourt, Nigeria.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Drug Resistance; HIV; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Protozoan Proteins | 2021 |
Heparin-decorated nanostructured lipid carriers of artemether-protoporphyrin IX-transferrin combination for therapy of malaria.
Topics: Animals; Artemether; Drug Carriers; Heparin; Lipids; Malaria; Mice; Nanostructures; Particle Size; Protoporphyrins; Rats; Transferrin | 2021 |
The pharmacokinetic properties of artemether and lumefantrine in Malaysian patients with Plasmodium knowlesi malaria.
Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Middle Aged; Plasmodium knowlesi | 2022 |
An assessment of the knowledge, practices and resources during the delivery of malaria health care services among private health care practitioners: a cross section study in the Mid-Western Region of Uganda.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Delivery of Health Care; Health Facilities; Humans; Malaria; Private Sector; Uganda | 2021 |
Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Colombia; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Young Adult | 2017 |
On assessing bioequivalence and interchangeability between generics based on indirect comparisons.
Topics: Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; Computer Simulation; Confidence Intervals; Drugs, Generic; Ethanolamines; Fluorenes; HIV Infections; Humans; Lamivudine; Lumefantrine; Malaria; Models, Statistical; Therapeutic Equivalency; Zidovudine | 2017 |
Market for Artemether-Lumefantrine to treat childhood malaria in a district of southern Mozambique.
Topics: Antimalarials; Artemether; Child; Child, Preschool; Drug Therapy, Combination; Female; Financing, Personal; Health Services Needs and Demand; Humans; Infant; Lumefantrine; Malaria; Male; Mozambique; Outcome Assessment, Health Care; Regression Analysis | 2017 |
Development and in vitro/in vivo evaluation of artemether and lumefantrine co-loaded nanoliposomes for parenteral delivery.
Topics: Animals; Antimalarials; Artemether; Drug Liberation; Liposomes; Lumefantrine; Malaria; Mice; Nanoparticles; Tissue Distribution | 2019 |
The course of pregnancy and delivery in a patient with malaria.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Female; Humans; Infant, Newborn; Malaria; Male; Poland; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Diagnosis; Tanzania; Travel | 2017 |
Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Cardiotoxicity; Disease Models, Animal; Electrocardiography; Female; Malaria; Male; Mice; Mice, Inbred C57BL; Nanocapsules; Plasmodium berghei | 2018 |
Level A in vitro-in vivo correlation: Application to establish a dissolution test for artemether and lumefantrine tablets.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Solubility; Tablets; Young Adult | 2018 |
Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Biological Availability; Drug Delivery Systems; Emulsions; Lumefantrine; Malaria; Male; Particle Size; Rats | 2018 |
Quality of the antimalarial medicine artemether - lumefantrine in 8 cities of the Democratic Republic of the Congo.
Topics: Antimalarials; Artemether; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Congo; Drug Contamination; Drug Stability; Humans; Lumefantrine; Malaria; Quality Control | 2018 |
Assessing the consistency assumptions underlying network meta-regression using aggregate data.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Bayes Theorem; Data Interpretation, Statistical; Humans; Malaria; Models, Statistical; Network Meta-Analysis; Odds Ratio; Quinine; Regression Analysis; Reproducibility of Results; Research Design | 2019 |
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult | 2019 |
[The treatment of malaria].
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Malaria Vaccines; Male; Netherlands; Pregnancy; Travel | 2019 |
Resolution pattern of jaundice among children presenting with severe malaria in rural South-West Nigeria.
Topics: Artemether; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Jaundice; Malaria; Male; Nigeria; Quinine; Rural Population; Time Factors; Treatment Outcome | 2012 |
Effect of chloroquine, methylene blue and artemether on red cell and hepatic antioxidant defence system in mice infected with Plasmodium yoelii nigeriensis.
Topics: Animals; Antimalarials; Antioxidants; Artemether; Artemisinins; Chloroquine; Erythrocytes; Liver; Malaria; Methylene Blue; Mice; Oxidative Stress; Plasmodium yoelii | 2013 |
Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Disease Models, Animal; Ethanolamines; Fluorenes; Lipids; Lumefantrine; Malaria; Male; Mice; Parasitemia; Plasmodium berghei | 2013 |
Plasmodium knowlesi infection imported to Germany, January 2013.
Topics: Acute Kidney Injury; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Germany; Humans; Lumefantrine; Malaria; Microscopy; Middle Aged; Plasmodium knowlesi; Polymerase Chain Reaction; Thailand; Travel; Treatment Outcome | 2013 |
The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Carbamates; Carbon; Crystallography, X-Ray; Dimerization; Drug Therapy, Combination; Malaria; Mefloquine; Mice; Molecular Conformation; Plasmodium berghei; Structure-Activity Relationship; Survival Analysis | 2014 |
The effect of lopinavir/ritonavir on the antimalarial activity of artemether or artemether/lumefantrine in a mouse model of Plasmodium berghei.
Topics: Animals; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Coinfection; Disease Models, Animal; Drug Combinations; Drug Interactions; Ethanolamines; Fluorenes; HIV Infections; Lopinavir; Malaria; Mice; Plasmodium berghei; Ritonavir | 2015 |
Preliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas.
Topics: Administration, Rectal; Age Factors; Animals; Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Azithromycin; Biological Availability; Capsules; Chemistry, Pharmaceutical; Crystallization; Crystallography, X-Ray; Drug Combinations; Endemic Diseases; Excipients; Humans; Malaria; Powder Diffraction; Rabbits; Solubility; Tablets; Technology, Pharmaceutical | 2014 |
Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Carriers; Ethanolamines; Fluorenes; Lipids; Lumefantrine; Malaria; Mice; Nanostructures; Particle Size; Plasmodium berghei | 2016 |
Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Coinfection; Diagnostic Tests, Routine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; Longitudinal Studies; Lumefantrine; Malaria; Male; Plasmodium; Plasmodium falciparum; Plasmodium ovale; Point-of-Care Systems; Prevalence; Uganda | 2014 |
Enhanced antimalarial activity by a novel artemether-lumefantrine lipid emulsion for parenteral administration.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Emulsions; Ethanolamines; Female; Fluorenes; Lumefantrine; Malaria; Male; Mice; Plasmodium berghei | 2014 |
[Diagnosis of the first imported case of Plasmodium ovale infection at Guangdong Port].
Topics: Artemether; Artemisinins; China; DNA Primers; Humans; Malaria; Microscopy; Myanmar; Plasmodium ovale; Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction | 2014 |
Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Malaria; Male; Mice; Plasmodium berghei; Rifampin; Survival Analysis | 2014 |
Antiplasmodial activity-aided isolation and identification of quercetin-4'-methyl ether in Chromolaena odorata leaf fraction with high activity against chloroquine-resistant Plasmodium falciparum.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Cell Line; Chloroquine; Chromolaena; Drug Resistance; Female; Inhibitory Concentration 50; Kaempferols; Lethal Dose 50; Malaria; Malaria, Falciparum; Male; Methyl Ethers; Mice; Plant Extracts; Plant Leaves; Plasmodium berghei; Plasmodium falciparum; Quercetin; Random Allocation | 2014 |
Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.
Topics: Adamantane; Animals; Anopheles; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Indoles; Insect Vectors; Lumefantrine; Malaria; Mice; Peroxides; Plasmodium berghei; Primaquine; Spiro Compounds | 2015 |
Formulation, characterization and anti-malarial activity of homolipid-based artemether microparticles.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Biological Availability; Cellulose; Chemistry, Pharmaceutical; Drug Carriers; Fats; Malaria; Mice; Parasitemia; Particle Size; Phosphatidylcholines; Plasmodium berghei; Seeds; Solubility | 2015 |
[Effect of a large scale community-based distribution of artemether-lumefantrine on its therapeutic efficacy among children living in a rural area of Burkina Faso].
Topics: Antimalarials; Artemether; Artemisinins; Burkina Faso; Child, Preschool; Delivery of Health Care; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Male; Population Density; Randomized Controlled Trials as Topic; Rural Population; Sample Size; Treatment Outcome | 2015 |
CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.
Topics: Alkynes; Anti-HIV Agents; Antimalarials; Artemether; Artemisinins; ATP Binding Cassette Transporter, Subfamily B; Benzoxazines; Case-Control Studies; Coinfection; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Drug Antagonism; Drug Therapy, Combination; Ethanolamines; Fluorenes; Genotype; HIV Infections; Humans; Lumefantrine; Malaria; Nevirapine; Prospective Studies | 2016 |
The Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural Kenya.
Topics: Antimalarials; Artemether; Artemisinins; Awareness; Caregivers; Child, Preschool; Community Health Services; Community Participation; Cross-Sectional Studies; Ethanolamines; Family Characteristics; Female; Fever; Fluorenes; Humans; Infant; Infant, Newborn; Kenya; Lumefantrine; Malaria; Male; Patient Acceptance of Health Care | 2015 |
Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
Topics: Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fever; Fluorenes; Health Services Accessibility; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Private Sector; Rural Population; Surveys and Questionnaires; Tanzania | 2012 |
The Impact of Inventory Management on Stock-Outs of Essential Drugs in Sub-Saharan Africa: Secondary Analysis of a Field Experiment in Zambia.
Topics: Antimalarials; Artemether; Artemisinins; Delivery of Health Care; Drugs, Essential; Ethanolamines; Fluorenes; Health Facilities; Health Planning; Humans; Lumefantrine; Malaria; Materials Management, Hospital; Models, Statistical; Pharmaceutical Services; Plasmodium falciparum; Workforce | 2016 |
Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.
Topics: Antimalarials; Artemether; Artemisinins; Biomedical Research; Chloroquine; Drug Combinations; Drug Resistance; Ethanolamines; Evidence-Based Medicine; Fluorenes; Health Policy; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2016 |
Teratogenicity of Artemether-Clindamycin Nanostructured Lipid Carriers in Rats.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Clindamycin; Diglycerides; Drug Carriers; Female; Malaria; Male; Maternal-Fetal Exchange; Mice; Monoglycerides; Nanostructures; Pregnancy; Rats, Sprague-Dawley | 2016 |
Artemether-lumefantrine nanostructured lipid carriers for oral malaria therapy: Enhanced efficacy at reduced dose and dosing frequency.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drug Carriers; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lipids; Lumefantrine; Malaria; Male; Mice; Nanostructures; Plasmodium berghei; Rats; Rats, Wistar; Treatment Outcome | 2016 |
Health worker and policy-maker perspectives on use of intramuscular artesunate for pre-referral and definitive treatment of severe malaria at health posts in Ethiopia.
Topics: Administrative Personnel; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Ethiopia; Female; Health Personnel; Humans; Injections, Intramuscular; Interviews as Topic; Malaria; Male; Quinine; Young Adult | 2016 |
Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola.
Topics: Angola; Antimalarials; Artemether; Artemisinins; Drug Costs; Drug Therapy, Combination; Ethanolamines; Financing, Government; Fluorenes; Health Services Accessibility; Humans; Lumefantrine; Malaria; Marketing of Health Services; Pharmacies; Private Sector | 2016 |
Spontaneous splenic rupture from Plasmodium ovalae malaria.
Topics: Abdomen; Adult; Africa, Central; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Endemic Diseases; Ethanolamines; Fluorenes; Humans; Laparoscopy; Lumefantrine; Malaria; Male; Plasmodium ovale; Splenectomy; Splenic Rupture; Tomography, X-Ray Computed | 2017 |
Engineering of microcomplex of artemether and lumefantrine for effective drug treatment in malaria.
Topics: Antimalarials; Artemether; Artemisinins; beta-Cyclodextrins; Citric Acid; Drug Carriers; Drug Interactions; Drug Liberation; Ethanolamines; Fluorenes; Lumefantrine; Malaria; Microspheres; Particle Size; Pyrrolidines; Vinyl Compounds | 2017 |
Impact of Extended Duration of Artesunate Treatment on Parasitological Outcome in a Cytocidal Murine Malaria Model.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Malaria; Mice; Mice, Inbred BALB C; Quinolines | 2017 |
Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chromatography, High Pressure Liquid; Drug Carriers; Drug Compounding; Emulsions; Lethal Dose 50; Malaria; Male; Mice; Oils; Particle Size; Plasmodium berghei; Solubility; Surface-Active Agents; Toxicity Tests | 2008 |
Development of SMEDDS using natural lipophile: application to beta-Artemether delivery.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Artemisinins; Biological Availability; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Emulsions; Lethal Dose 50; Malaria; Male; Mice; Oils; Particle Size; Plasmodium berghei; Solubility; Surface-Active Agents | 2008 |
Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Carriers; Drug Compounding; Drug Design; Emulsions; Erythrocytes; Hemolysis; Humans; In Vitro Techniques; Injections; Liposomes; Malaria; Male; Mice; Particle Size; Plasmodium berghei; Survival Analysis | 2008 |
Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Ethanolamines; Fluorenes; Guideline Adherence; Health Policy; Health Services Research; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Middle Aged; Uganda | 2008 |
Antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Biological Availability; Drug Therapy, Combination; Ethanolamines; Fats; Fluorenes; Humans; Lumefantrine; Malaria; Quinolines; Treatment Failure | 2009 |
Advances in global biotechnology and local resources to treat malaria.
Topics: Antimalarials; Artemether; Artemisia; Artemisinins; Artesunate; Drug Approval; Drug Resistance, Multiple; Drugs, Investigational; Global Health; Humans; Malaria; Minnesota; Phytotherapy | 2009 |
First artemisinin-based antimalarial combination approved for U.S. market.
Topics: Administration, Oral; Antimalarials; Artemether; Artemisinins; Drug Approval; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Tablets; United States; United States Food and Drug Administration | 2009 |
Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma.
Topics: Antimalarials; Artemether; Artemisinins; Calibration; Chromatography, High Pressure Liquid; Formates; HIV Infections; Humans; Malaria; Models, Chemical; Quality Control; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors | 2009 |
Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: Pharmacokinetics, toxicological and in vivo anti-malarial activity.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Carriers; Drug Compounding; Lipids; Malaria; Mice; Nanoparticles; Particle Size; Plasmodium berghei; Technology, Pharmaceutical | 2010 |
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia.
Topics: Acute Kidney Injury; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Ethanolamines; Female; Fluorenes; Hospitals, Urban; Humans; Lumefantrine; Malaria; Malaysia; Microscopy; Middle Aged; Parasitemia; Patient Selection; Plasmodium knowlesi; Polymerase Chain Reaction; Quinine; Respiratory Distress Syndrome; Severity of Illness Index; Shock; Survival Rate | 2011 |
Plasmodium knowlesi reinfection in human.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Blood Transfusion; Doxycycline; Ethanolamines; Fluorenes; Hemolysis; Humans; Lumefantrine; Malaria; Malaysia; Male; Mefloquine; Microscopy; Phylogeny; Plasmodium knowlesi; Polymerase Chain Reaction; Protozoan Proteins; Quinine; Recurrence | 2011 |
Presumptive treatment to reduce imported malaria among refugees from east Africa resettling in the United States.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Pyrimethamine; Refugees; Sulfadoxine; Tanzania; United States | 2011 |
Plasmodium species co-infection as a cause of treatment failure.
Topics: Antimalarials; Artemether; Artemisinins; Australia; Coinfection; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Plasmodium malariae; Travel; Treatment Outcome; Uganda | 2011 |
Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication?
Topics: Adult; Animals; Antibodies, Protozoan; Antimalarials; Artemether; Artemisinins; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Plasmodium falciparum; Plasmodium malariae | 2012 |
Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation.
Topics: Administration, Intravenous; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Treatment Outcome | 2012 |
Neurotoxicity and efficacy of arteether related to its exposure times and exposure levels in rodents.
Topics: Animals; Anorexia; Antimalarials; Area Under Curve; Artemether; Artemisinins; Biological Availability; Malaria; Male; Mice; Muscle, Skeletal; Neurotoxins; Plasmodium berghei; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tissue Distribution | 2002 |
Recent studies have reported significant toxicity of artemisinin and its derivatives for schistosomula in various Schistosoma species.
Topics: Africa; Animals; Artemether; Artemisinins; Child; Clinical Trials as Topic; Female; Humans; Malaria; Male; Schistosomiasis; Schistosomicides; Sesquiterpenes | 2003 |
Selection and reversal of Plasmodium berghei resistance in the mouse model following repeated high doses of artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Disease Models, Animal; Drug Resistance; Female; Immunity, Innate; Malaria; Male; Mice; Mice, Inbred Strains; Naphthyridines; Plasmodium berghei; Sesquiterpenes | 2004 |
Laboratory evaluation of the ict malaria P.f./P.v. immunochromatographic test for detecting the panmalarial antigen using a rodent malaria model.
Topics: Animals; Antigens, Protozoan; Antimalarials; Artemether; Artemisinins; Chromatography; Disease Models, Animal; False Negative Reactions; False Positive Reactions; Female; Fructose-Bisphosphate Aldolase; Malaria; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Plasmodium vivax; Reagent Kits, Diagnostic; Sensitivity and Specificity; Sesquiterpenes | 2004 |
Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Stability; Fluorine; Hydrolysis; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 2004 |
[Additive therapeutic effect of a combination of artemether and daphnetin against Plasmodium berghei in mice].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Female; Malaria; Male; Mice; Plasmodium berghei; Sesquiterpenes; Umbelliferones | 2004 |
Treating severe malaria.
Topics: Administration, Rectal; Antimalarials; Artemether; Artemisinins; Child; Humans; Infusions, Intravenous; Malaria; Quinine; Sesquiterpenes; Suppositories | 2005 |
Convenient access both to highly antimalaria-active 10-arylaminoartemisinins, and to 10-alkyl ethers including artemether, arteether, and artelinate.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Malaria; Mice; Molecular Structure; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Sesquiterpenes | 2005 |
Examples of tropical disease control in the humanitarian medical programmes of MSF and Merlin.
Topics: Antimalarials; Artemether; Artemisinins; Attitude to Health; Child; Child, Preschool; Communicable Disease Control; Cross Infection; Eflornithine; Ethanolamines; Ethiopia; Female; Fluorenes; Humans; Lassa Fever; Lumefantrine; Malaria; Medical Missions; Pregnancy; Sierra Leone; Sudan; Trypanocidal Agents; Trypanosomiasis, African; Tuberculosis, Pulmonary; USSR | 2006 |
A case-control auditory evaluation of patients treated with artemether-lumefantrine.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Aged; Antimalarials; Artemether; Artemisinins; Audiometry; Case-Control Studies; Child; Drug Therapy, Combination; Ethanolamines; Evoked Potentials, Auditory, Brain Stem; Female; Fluorenes; Hearing Loss; Humans; Lumefantrine; Malaria; Male; Middle Aged; Treatment Outcome | 2006 |
Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Drug Therapy, Combination; Female; Humans; Intestines; Liver; Malaria; Mice; Parasitemia; Plasmodium berghei; Praziquantel; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides | 2006 |
Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana.
Topics: Antimalarials; Artemether; Artemisinins; Caregivers; Child, Preschool; Clinical Competence; Community Health Services; Drug Administration Schedule; Drug Combinations; Ethanolamines; Feasibility Studies; Female; Fluorenes; Ghana; Home Nursing; Humans; Infant; Lumefantrine; Malaria; Male; Patient Acceptance of Health Care; Patient Compliance | 2006 |
First Brazilian experience with the use of artemether-lumefantrine (Coartem) a fixed-dosed ACT combination.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Brazil; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Time Factors; World Health Organization | 2006 |
The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.
Topics: Adolescent; Adult; Anti-Infective Agents; Antimalarials; Artemether; Artemisinins; Diagnostic Errors; Ethanolamines; Fever; Fluorenes; Health Care Costs; Humans; Kenya; Lumefantrine; Malaria; Microscopy; Models, Economic; Prevalence; Sensitivity and Specificity | 2006 |
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Erythrocytes; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Peroxides; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinolines; Spiro Compounds | 2007 |
Changes in the visceral functions of Plasmodium berghei-infected and -uninfected rats following administration of artemether.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Dose-Response Relationship, Drug; Drinking; Eating; Female; Malaria; Male; Plasmodium berghei; Rats; Rats, Wistar; Urine | 2006 |
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Design; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Global Health; Half-Life; Humans; Lumefantrine; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Proguanil; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 2007 |
[Artemether-lumefantrine, treatment of child more than 5 years old uncomplicated malaria in Tsevie's hospital (Togo)].
Topics: Antimalarials; Artemether; Artemisinins; Child; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Safety | 2007 |
An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria.
Topics: Adolescent; Adult; Animals; Antigens, Protozoan; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Support Techniques; Decision Trees; Diagnostic Tests, Routine; Ethanolamines; Fluorenes; Humans; L-Lactate Dehydrogenase; Lumefantrine; Malaria; Plasmodium; Protozoan Proteins; Sensitivity and Specificity; Uganda; Urban Population | 2008 |
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.
Topics: Adult; Antimalarials; Artemether; Artemisinins; Case Management; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Government Programs; Guideline Adherence; Health Personnel; Humans; Kenya; Lumefantrine; Malaria; Male; Middle Aged; Rural Population; Surveys and Questionnaires | 2008 |
Malaria in Egypt, Saudi Arabia and Yemen: a clinical pilot study.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Chloroquine; Egypt; Female; Humans; Infant; Malaria; Male; Mefloquine; Middle Aged; Pilot Projects; Quinine; Saudi Arabia; Severity of Illness Index; Yemen | 2007 |
[Antimalarial effect and toxicity of methyl-dihydro-artemisinine in animals (author's transl)].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Dogs; Female; Malaria; Male; Mice; Pyrans; Rabbits; Rats; Sesquiterpenes | 1981 |
[A combined regimen of pyronaridin-artemether-chloroquine (PAC) for the treatment of Plasmodium cynomolgi infection in the rhesus monkey].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Therapy, Combination; Macaca mulatta; Malaria; Naphthyridines; Pyrans; Sesquiterpenes | 1984 |
Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Brain Diseases; Child; Child, Preschool; Female; Humans; Malaria; Male; Middle Aged; Plasmodium falciparum; Sesquiterpenes | 1982 |
[Clinical study on the use of artemether in treating pernicious malaria].
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Female; Humans; Malaria; Male; Middle Aged; Pyrans; Sesquiterpenes | 1982 |
[Complicated malaria tropica--therapy with artemether].
Topics: Adult; Antimalarials; Artemether; Artemisinins; Cambodia; Critical Care; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Malaria; Malaria, Cerebral; Male; Pregnancy; Pregnancy Complications, Parasitic; Sesquiterpenes | 1994 |
Antimalarial activity of dihydroartemisinin derivatives by transdermal application.
Topics: Administration, Cutaneous; Animals; Antimalarials; Artemether; Artemisinins; Gels; Malaria; Mice; Plasmodium berghei; Sesquiterpenes; Structure-Activity Relationship | 1994 |
[Studies on the establishment of malarial animal model of short-term relapse. IV. Short-term relapse in rhesus monkeys infected with sporozoites of Plasmodium cynomolgi].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Drug Therapy, Combination; Erythrocytes; Macaca mulatta; Malaria; Naphthyridines; Plasmodium cynomolgi; Recurrence; Sesquiterpenes | 1993 |
[Studies on the establishment of malarial animal model of short-term relapse. III. Combined therapy with pyronaridine-artemether-chloroquine for parasitemia clearance].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Drug Therapy, Combination; Macaca mulatta; Malaria; Naphthyridines; Plasmodium cynomolgi; Recurrence; Sesquiterpenes | 1993 |
Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
Topics: Animals; Antimalarials; Aotus trivirgatus; Artemether; Artemisinins; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Malaria; Malaria, Falciparum; Male; Mefloquine; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship | 1993 |
Ammunition against malaria.
Topics: Antimalarials; Artemether; Artemisinins; Canada; Humans; Malaria; Sesquiterpenes | 2001 |
Potent antimalarial activities of polyether antibiotic, X-206.
Topics: Actinomycetales; Animals; Anti-Bacterial Agents; Antimalarials; Artemether; Artemisinins; Artesunate; Cell Death; Cell Line; Chloroquine; Drug Resistance; Embryo, Mammalian; Embryo, Nonmammalian; Ethers, Cyclic; Humans; Malaria; Mice; Molecular Structure; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinine; Sesquiterpenes | 2001 |
A comparison of the stage-specific efficacy of chloroquine, artemether and dioncophylline B against the rodent malaria parasite Plasmodium chabaudi chabaudi in vivo.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Female; Isoquinolines; Life Cycle Stages; Malaria; Mice; Parasitemia; Plasmodium chabaudi; Sesquiterpenes | 2001 |
Preparation of beta-artemether liposomes, their HPLC-UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Liposomes; Malaria; Mice; Parasitemia; Plasmodium chabaudi; Secondary Prevention; Sesquiterpenes; Spectrophotometry, Ultraviolet | 2002 |
Follow-up observation on the therapeutic effects and remote reactions of artemisinin (Qinghaosu) and artemether in treating malaria in pregnant woman.
Topics: Antimalarials; Artemether; Artemisinins; Female; Follow-Up Studies; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious; Sesquiterpenes | 1989 |
[Effects of artemether on red blood cell immunity in malaria].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Erythrocyte Membrane; Female; Macaca mulatta; Malaria; Male; Mice; Mice, Inbred BALB C; Plasmodium; Plasmodium berghei; Pyrans; Sesquiterpenes | 1986 |
Experimental studies on the antimalarial activity estimation by artesunate and artemether preparations per skin absorption.
Topics: Administration, Cutaneous; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Female; Malaria; Male; Mice; Plasmodium berghei; Sesquiterpenes; Skin Absorption | 1988 |
The combined use of artemether, sulfadoxine and pyrimethamine in the treatment of uncomplicated falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemether; Artemisinins; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Male; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Sulfanilamides; Time Factors | 1988 |
[Combined use of artemether with other antimalarials in the treatment of falciparum malaria].
Topics: Adolescent; Adult; Artemether; Artemisinins; Child; Child, Preschool; Drug Therapy, Combination; Humans; Malaria; Middle Aged; Nitroquinolines; Plasmodium falciparum; Primaquine; Pyrans; Sesquiterpenes; Sulfadoxine | 1987 |
[Clinical study on the treatment of malaria with artemether and artesunate].
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrans; Recurrence; Sesquiterpenes | 1988 |
[Development of a qinghaosu-resistant line of Plasmodium berghei ANKA and N strain].
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Microbial; Malaria; Male; Mice; Plasmodium berghei; Primaquine; Pyrans; Sesquiterpenes | 1986 |
The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Malaria; Male; Mice; Pigments, Biological; Plasmodium berghei; Pyrans; Sesquiterpenes | 1986 |
Sensitivity of malaria parasites to artemether (qinghaosu derivative) depends on host cell age.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Erythrocyte Aging; Erythrocytes; Malaria; Mice; Plasmodium berghei; Sesquiterpenes | 1987 |
The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma.
Topics: Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Pyrans; Pyrimethamine; Quinine; Sesquiterpenes; Sulfadoxine | 1986 |
A case of black water fever treated with peritoneal dialysis and artemether (quinghaosu derivative).
Topics: Artemether; Artemisinins; Blackwater Fever; Humans; Malaria; Middle Aged; Peritoneal Dialysis; Pyrans; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1987 |
[The combined use of artemether, sulfadoxine, pyrimethamine and primaquine in the treatment of chloroquine-resistant falciparum malaria].
Topics: Adult; Animals; Antimalarials; Artemether; Artemisinins; Child; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria; Male; Plasmodium falciparum; Primaquine; Pyrans; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 1985 |
Clinical studies of treatment of falciparum malaria with artemether, a derivative of qinghaosu.
Topics: Antimalarials; Artemether; Artemisinins; Humans; Malaria; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Plasmodium falciparum; Pyrans; Sesquiterpenes | 1985 |